glp 1 drugs tirzepatide Understand GLP-1/GIP Dual Agonist and Its Effect on Current Weight Loss Therapy GLP-1 Drug, Tirzepatide May Offer
Description
Differentiation, 120 , 19
The FDA has not approved compounded versions of these drugs, and such products may carry safety, quality, and effectiveness risks due to variations in formulation, incorrect ingredients, improper storage, or inaccurate dosing
However, the potential protective effects of these agents on recurrence and survival in BC patients are unclear
Hart, P
